Our Team
Christopher W. Kersey, MD MBA
Dr. Kersey serves as a Managing Member of Camden Partners in Baltimore, Maryland, where he focuses on growth equity investments in the health care and life science industries. Founded in 1995, Camden Partners is one of the largest growth equity and investment management funds in the United States with more than $700 million under management.
Prior to joining Camden Partners, he served as a Managing Director of Cogene Ventures, at the time the largest health care and life science growth equity fund in the Southern tier of the United States. Chris began his career as an Associate at the venerable Menlo Ventures where he focused on health care and life science investments.
Dr. Kersey currently serves on the board of directors of LipoScience Inc., MinSec Holdings Inc. and PatientSafe Solutions Inc., and he is a board observer of AtriCure Corporation (NASDAQ: ATRC) and Picis Inc. Dr. Kersey’s previous portfolio companies include MedServe Inc. (acquired by Stericycle Corporation, NASDAQ: SRCL), AlgoRx Pharmaceuticals Inc. (acquired by Anesiva Corporation, NASDAQ: ANSV), ComView Medical Systems (acquired by ElectroMed Corporation), MacroGenics Inc., Pet DRx Corporation (acquired by VCA Antech Inc., NASDAQ: WOOF), Rejuvenon Corporation (acquired by Helsinn Healthcare S.A.) and Xeotron Corporation (acquired by Life Technologies Corporation, NASDAQ: LIFE).
Dr. Kersey serves on the board of trustees of Johns Hopkins Medicine and the board of trustees of the Johns Hopkins Hospital.
Chris received his B.A. degree from Stanford University, his M.B.A. degree from the Harvard Business School and his M.D. degree from the Emory University School of Medicine.
Telephone: 410-878-6815
Executive Assistant: Shawn Sterling
